Microbials
Fermentation products such as probiotics, enzymes and silage inoculants improve animal survival rates, boost average daily weight gains, and increase feed efficiency.
- Direct-fed
microbials or probiotics —Feed
and animal health industries have significantly increased their use
of direct-fed microbials—also called probiotics—to
optimize conditions in the digestive tract. Probiotic refers to the
symbiotic relationship between bacteria and the host animal. Each bacteria
from our collection of more than 250 host specific strains has been
tested and documented for its ability to grow and multiply in the host
-animal gut environment. A/B Technologies is an industry leader in the
development and use of avian, bovine, equine and porcine strains. Bacteria
are antibiotic compatible and microencapsulated for maximum shelf-life,
stability and viability. They are safety tested and documented for registration.
- Enzymes
—A feed supplement,
enzymes enhance the digestive process by breaking down the feed to maximize the
animal's nutrient use. Tests have been conducted to show the benefits of using
enzymes in feed rations. These include: lengthening the digestive tract, increasing
bone structure, improving lean meat ratios, and accelerated antibiotic absorption.
- Silage Inoculants —We can selectively incorporate specific enzymes and carbohydrates to enhance the performance of your bacterial blends. Through these technologies, we have successfully developed inoculants that are highly successful in conditions that range from wet European grasses to high moisture grains. Our research has enabled us to produce inoculants that are specific to different ensiling situations, allowing our clients to customize products for their customers' specific conditions.
Antibodies
A safe, natural product of the immune system, antibodies offer a major technical development for the new millineum. They can now be produced as specific components at precise concentrations. And because they neither produce residues or build up resistance factors, they satisfy growers' and consumers' desire for natural food products.
In cooperation with our joint venture partner, A/B Technologies leads the industry in the development of cost-effective polyclonal antibody technology. Our ability to produce dry, stable antibodies at a competitive price enables us to provide products to our clients that offer significant benefits, especially for newborn and young animals.
At present, we have developed the technology to produce antibodies for strains of E.coli, salmonella, and rotavirus. Full documentation and potency data are available on each antibody, which can be used for registration.
As the industry capitalizes on the advantages of antibody use, this technology will become more widespread in the coming decade.
